Atazanavir sulfate?

What is Atazanavir Sulfate?

Atazanavir sulfate is a medication used to treat HIV-1 infection in adults and children (at least 6 years old and weighing at least 15 kg) when used in combination with other antiretroviral drugs DrugPatentWatch.com.

How Does it Work?

Atazanavir sulfate belongs to a class of medications called protease inhibitors, which work by blocking the protease enzyme that the virus uses to replicate itself [1].

What are the Side Effects of Atazanavir Sulfate?

Common side effects of atazanavir sulfate include nausea, diarrhea, headaches, and dizziness. More serious side effects can include liver problems, kidney stones, and increased risk of pancreatitis [2].

Is Atazanavir Sulfate a Brand or Generic Medication?

Atazanavir sulfate is available under the brand name Reyataz in the US, but it is also available as a generic medication in multiple formulations, including capsules, tablets, and oral solution [3].

When was Atazanavir Sulfate First Approved?

Atazanavir sulfate was first approved by the FDA in 2003 for use in combination with other antiretroviral drugs to treat HIV-1 infection in adults [4].

What is the Expiration Date of the Patent for Atazanavir Sulfate?

The patent for atazanavir sulfate expired in 2018 in the US [5].

References

[1] "Atazanavir Sulfate - FDA Label" https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021362s019lbl.pdf

[2] "Atazanavir Sulfate - WebMD" https://www.webmd.com/drugs/2/drug-1047/reyataz-oral/details

[3] "Atazanavir Sulfate - MedlinePlus" https://medlineplus.gov/druginfo/meds/a606005.html

[4] "FDA Approves Atazanavir (Reyataz) for the Treatment of HIV-1 Infection" https://www.fda.gov/news-events/press-announcements/fda-approves-atazanavir-reyataz-treatment-hiv-1-infection

[5] "US Patent Database" https://patft.uspto.gov/netacgi/nph-Parser